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Liver regeneration is known to occur in mice lacking one or more Toll-like receptors (TLRs) or the adaptor protein MyD88.
Though MyD88 is required for signaling by many TLRs, others signal via MyD88-independent pathways, leading to the induction
of type I interferons (IFNs). Here, we assessed liver regeneration after partial hepatectomy (PH) in mice lacking both MyD88 and
the type I IFN receptor (Myd88-IFNAR double-KO). Approximately 28% of Myd88-IFNAR double-KO mice had gross liver lesions
prior to surgery. In mice without lesions, Myd88-IFNAR deﬁciency abrogated the increase in circulating IL-6 after PH but did not
impair hepatocyte BrdUincorporation, mitotic ﬁgure counts, or recovery of liver-to-body weight ratios. These results indicate that
type I IFNs are not responsible for the preservation of liver regeneration in Myd88-deﬁcient mice, and they also cast doubt on the
idea of microbial products being essential triggers of liver regeneration in mice undergoing PH.
1.Introduction
Liver regeneration after partial hepatectomy (PH) depends
on the ability of hepatocytes and nonparenchymal cells
(NPCs) to rapidly integrate multiple signals originating
from immune, hormonal, and metabolic networks [1, 2]. A
consequence of such integration is the induction of proin-
ﬂammatory cytokines (tumor-necrosis-factor- (TNF-) α, in-
terleukin- (IL-) 6) in the liver, most likely in resident macro-
phages (Kupﬀer cells) [3–5]. In mice, this cytokine activation
results in an early increase of IL-6 in the circulation, which
modulates a variety of genes involved in cell proliferation,
survival, and the acute phase response [6, 7].
Early studies performed in germ-free, lipopolysaccha-
ride- (LPS-) resistant, and antibiotic-treated rodents sug-
gestedthatmicrobialproductsfromintestinalbacteriareach-
ing the remnant liver in relative excess are responsible for
triggering liver regeneration after PH [8, 9]. It is now known
that the cellular detection of microbial components mostly
relies on the recognition of pathogen-associated molecular
patterns (PAMPs) by the evolutionarily conserved Toll-like
(TLR)/IL-1 family of receptors, although non-TLR pathways
also exist [10, 11]. In accordance with the notion that
intestinal bacteria trigger liver regeneration, several studies
have consistently shown an abrogation of circulating IL-6
after 2/3 PH in mice deﬁcient in MyD88, an adaptor protein
forallTLR/IL-1receptorsexceptTLR-3[12–14].Inadetailed
assessment of mice lacking one or more TLR genes, we
recently reported that up to 60% of the increase in IL-6
after PH depends on signaling by the LPS receptor TLR-4,
but other MyD88-dependent ligands/receptors contributing
to IL-6 production could not be identiﬁed [15]. Despite the
contributions of TLR-4 and MyD88 to IL-6 production after
PH, full restitution of liver mass after PH was observed in
mice lacking one or more TLRs, including Tlr4 KO, Tlr2 KO,
Tlr9 KO, Tlr2,4 double-KO, Tlr2,4,9 triple-KO, and Tlr2,4-
caspase-1 t r i p l e - K Om i c e ,a sw e l la si nMyd88 KO mice
[12, 13, 15]. Whereas the deﬁciency of Myd88 resulted in
an earlier initiation of hepatocyte proliferation under our
experimental conditions [15], Seki et al. found a transient
impairment of hepatocyte proliferation in the same mouse
strain [12]. Remarkably, all studies showed that Myd88-null
mice regenerated their livers to the same extent as littermate
controls, despite the profound defect in IL-6 production.2 Gastroenterology Research and Practice
In a separate study, a transient acceleration of hepatocyte
proliferation after PH was described in mice deﬁcient in Tlr3
[16], a TLR that signals via a MyD88-independent pathway
resulting in the induction of interferon- (IFN-) α and β.
These IFNs, which may also be induced by TLR-4 in a
MyD88-independentmanner,signalviathetypeIIFNrecep-
tor (IFNAR), and characteristically result in the induction
of proinﬂammatory cytokines and chemokines with potent
antiviral, antibacterial, and antitumoral properties [17].
A potential explanation for the mild eﬀects of TLR
and MyD88 deﬁciencies on murine liver regeneration may
be the great degree of redundancy and cooperation that
exist between TLRs and among other non-TLR pattern-
recognition receptors [11]. It is conceivable that, after PH,
multiple microbial products (lipoproteins, LPS, DNA, etc.)
may simultaneously activate diﬀerent TLRs in the same
and/or in diﬀerent cells. In addition, TLR signaling via
MyD88-independent pathways could still occur in Myd88-
deﬁcient mice. Here, we evaluated liver regeneration in mice
with simultaneous deﬁciency of Myd88 and IFNAR genes
to provide further insight into these possibilities. We report
that liver regeneration after PH is preserved in Myd88-
IFNAR double-KO mice, indicating that type I IFNs are
not responsible for the preservation of liver regeneration in
Myd88-deﬁcient mice. Our results do not provide support
to the notion of microbial products from intestinal bacteria
being essential for murine liver regeneration after PH.
2.MaterialandMethods
2.1. Mice. Myd88-IFNAR double-knockout (KO) mice were
provided by Dr. C. Wilson (Department of Immunology,
University of Washington, Seattle, WA) and bred in such
a way that mice remained homozygous for the defective
alleles. C57Bl6/J wild-type (WT) mice were obtained from
The Jackson Lab and bred in parallel with the Myd88-IFNAR
double-KOmice.Allmicewerehousedinthesameroomina
speciﬁc pathogen-free facility with 12h light/dark cycles and
fed ad libitum.
Myd88-IFNAR double-KO mice were diﬃcult to breed,
often having a lower number of litters per breeding pair,
smaller litter sizes, and a higher tendency to have runted
mice than their WT controls. Early deaths also appeared to
be more common in Myd88-IFNAR double-KO mice; these
deaths were often (but not exclusively) around the time of
parturition in breeding females. The Institutional Animal
Care and Use Committee at the University of Washington
approved all studies.
2.2. Surgeries. Eight-to-twelve week-old male mice (weigh-
ing 20–25 grams) underwent 2/3 PH or sham laparotomy
under inhalational isoﬂuorane anesthesia (n = 3–13 per
genotype per time point). 2/3 PH consisted of a midline
laparotomy with removal of the left and anterior (median)
liverlobesandthegallbladder,asdescribedin[18].Thesham
laparotomy group consisted in gentle manipulation of liver
lobes without removal of liver tissue, following thereafter
the same assessments as mice undergoing 2/3 PH. Surgeries
were performed between 7 and 11:30AM in overnight-fasted
mice, and all mice received ∼0.7mL of intraperitoneal (IP)
sterile 0.9% saline before closing the abdomen, to correct
for ﬂuid losses. Mice rapidly regained consciousness and had
immediate access to food and water. They were euthanized
at indicated times by CO2 inhalation, with administration of
BrdU (50mg/kgIP) 2h before sacriﬁce. The development of
small areas of hepatocyte necrosis was observed in a small
percentage of mice of each genotype undergoing PH; these
mice were excluded from all analyses. Liver tissue was either
immersed in ﬁxative or snap-frozen and stored at −80◦C.
2.3. Retroorbital Bleeding Technique. A retroorbital bleeding
sample (150–200μL) was obtained 4h after surgery. For this
procedure, mice were reanesthetized with isoﬂuorane, and
blood was obtained via a heparinized Natelson capillary tube
(Fisher Scientiﬁc, Pittsburgh, PA) inserted via the medial
canthus approach. The whole procedure from induction to
recovery from anesthesia lasted approximately 5 minutes.
Blood was centrifuged and plasma stored at –80◦C.
2.4. Histology and Immunostaining. Liver and small intestine
were ﬁxed for 24h in Methacarn (60% methanol, 30% chlo-
roform, and 10% acetic acid: v/v/v), embedded in paraﬃn,
and cut in 6μm thick sections. BrdU immunostaining was
performed with a monoclonal anti-BrdU antibody (Dako
Corp, Carpinteria, CA) as described in [13]. Hepatocyte pro-
liferation was measured by the mean number of hepatocytes
with positive BrdU nuclear staining counted in eight 200×
microscopic ﬁelds (approximately 3,500 hepatocytes) and
the total number of mitotic ﬁgures in hepatocytes counted
in an equivalent area of adjacent, hematoxylin and eosin-
stained tissue. Proliferation of nonparenchymal cells (NPCs)
was assessed by the mean number of BrdU-labeled NPCs
counted in the same area as BrdU-labeled hepatocytes.
2.5. Determination of Circulating Cytokines in Plasma. We
measured the circulating concentration of IL-6 using a
mouse IL-6 ELISA kit (555240, BD Biosciences). We also
measured the concentrations of IL-6, TNF-α,I L - 1 β,I L - 1 2
p70, IL-10, IFN-γ, and VEGF using a bead-based cytometric
immunoassay system (Luminex, Austin, TX) according to
themanufacturer’sinstructions(R&DSystems,Minneapolis,
MN).
2.6. Statistics. Data are presented as mean ± SEM. Diﬀer-
ences were analyzed using U-Mann Whitney test or the
Kruskal Wallis test followed by Dunn’s test. A P value < 0.05
was considered signiﬁcant. Analyses were performed using
Prism 5.02 (GraphPad Software, Inc.).
3. Results
3.1. General Characteristics and Presence of Baseline Liver
Pathology in Myd88-IFNAR Double-KO Mice. For the
present study, we performed 2/3 PH or sham laparotomy in
8–12-week-old male C57Bl6 WT and Myd88-IFNAR double-
KO mice. No obvious external physical anomalies were ap-
parent in any of the mice prior to surgery. Unexpectedly,
at the time of laparotomy we found that a considerableGastroenterology Research and Practice 3
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Figure 1: Baseline liver lesions in Myd88-INFAR double-KO mice. (a) White lesions on the surface of multiple liver lobes from two male
Myd88-IFNAR double-KO mice (8 weeks old), detected at the time of laparotomy. Unaﬀected areas of the liver have a normal appearance.
Paraﬃn-embedded liver tissue sections (6μm) of abnormal livers were stained with hematoxylin and eosin and digitally captured at 40x (b),
100x (c), 200x (d), and 400x (e) magniﬁcation. (b) Large areas of hepatocellular necrosis across the liver lobes (indicated by arrowheads)
are surrounded by layers of hepatocytes with eosinophilic cytoplasm and dense inﬂammatory cell inﬁltrates (indicated by arrows). Adjacent
liver tissue within the same lobe looks normal. (c) Layers of hepatocytes with eosinophilic cytoplasm in zones I and II of the hepatic lobule,
with dense inﬂammatory cell inﬁltrates (arrows). (d) and (e) Details of zone I of a hepatic acinus showing a dense inﬂammatory reaction
composed of lymphocytic and polymorphonuclear cells. The inﬂammatory inﬁltrate encloses hepatocytes undergoing coagulative necrosis
(arrows) and a portal vein with histological features of endothelitis (asterisk). The hepatocytes that surround the inﬂammatory inﬁltration
have an altered cell shape, increased eosinophilia, and some show pyknotic nuclei suggestive of apoptosis (arrowheads).
proportion of Myd88-IFNAR double-KO mice had gross
liverabnormalities.Speciﬁcally,7of25(28%)Myd88-IFNAR
double-KOmicehadmacroscopicallyvisiblewhitelesionson
the liver surface, mostly on the median and left lateral lobes
(Figure 1(a)). These discolored areas were well demarcated
and ﬁrmer than the rest of the liver, and surrounding tis-
sues had often adhered to them. Microscopic examination
of these lesions revealed large areas of coagulative necrosis
(Figure 1(b)). The parenchyma surrounding the necrotic tis-
sue is composed of hepatocytes with increased eosinophilia;
some of these cells also have rounded morphology and
pyknotic nuclei suggestive of apoptosis. Dense foci of lym-
phocytic and polymorphonuclear cell inﬁltrates are partic-
ularly prominent in the portal and periportal areas of the
hepatic lobule, and they encircle hepatocytes undergoing ne-
crosis. Portal veins with histological features suggestive of
endothelitis are also seen (Figures 1(c)–1(e)). The parenchy-
ma surrounding the aﬀected areas as well as the parenchyma
of nonaﬀected lobes is remarkably normal.
Only Myd88-IFNAR double-KO mice that did not have
intraoperative liver pathology were included in the primary
analyses. Body weight was similar in WT and Myd88-IFNAR4 Gastroenterology Research and Practice
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Figure 2: Circulating levels of IL-6 in C57Bl6 WT mice and
Myd88-IFNAR double-KO mice after PH or sham laparotomy.
Blood samples were obtained from the retroorbital sinus at 4h after
surgery, and IL-6 was measured in plasma by ELISA. ∗∗P<0.01,
∗∗∗P<0.001.
double-KO mice at the time of surgery (21.2 ± 0.5gversus
21.1 ± 0.6g, NS), and they also gained similar body weight
during the ﬁrst 7 days after the PH (data not shown), sup-
porting the absence of serious illness in the Myd88-IFNAR
double-KO mice included in the analyses.
3.2. Deﬁcit in Circulating IL-6 Levels after PH in Myd88-
IFNAR Double-KO Mice. After PH, there is an early increase
of circulating IL-6 that has been shown to depend on
signaling through MyD88. In the present study, we measured
circulating levels of IL-6 by ELISA in retroorbital bleeding
samplesobtained4haftershamoperationorPH.Circulating
IL-6 is undetectable in nonoperated WT mice (data not
shown) and in sham-operated Myd88-IFNAR double-KO
mice (Figure 2). Plasma IL-6 markedly increases in WT mice
after PH, compared with a slight elevation observed after
sham laparotomy. The increase of circulating IL-6 after PH
is profoundly abrogated in Myd88-IFNAR double-KO mice,
whichhaveIL-6levelsequivalenttothosemeasuredinsham-
operated mice.
We then used the Luminex platform to assess whether
the double deﬁciency of Myd88 and IFNAR is associated
with changes in other circulating cytokines after PH. While
the Luminex assay conﬁrms the changes in IL-6 that we
had measured by ELISA (WT + sham: 193 ± 23, WT +
PH: 1732 ± 274, Myd88-IFNAR double-KO + PH: 139 ±
43pg/mL, P<0.01 WT + PH versus the rest), the circulating
concentrations of TNF-α,I L - 1 β, IL-12 p70, IL-10, and IFN-
γ are below the range of detection of the assay in the vast
majority of WT and Myd88-IFNAR double-KO mice after
sham operation, as well as after PH. Circulating levels of
VEGF are detectable in sham-operated WT mice and they
tend to decrease to a similar extent after PH in both WT and
Myd88-IFNAR double-KO mice (WT + sham: 94.5 ± 27.8,
WT + PH: 30.3 ± 2.0, Myd88-IFNAR double-KO + PH:
34.8 ±2.0pg/mL,P = 0.054).
3.3. Preserved Liver Regeneration in Myd88-IFNAR Double-
KO Mice without Preexisting Liver Pathology. All Myd88-
IFNAR double-KO mice without preexisting liver pathology
that underwent PH survived, and they do not have increased
rates of postoperative hepatocellular necrosis compared with
WTmice.Theratiosoftheweightoftheresectedliverlobules
in relation to the body weight were similar in WT mice
and Myd88-IFNAR double-KO mice undergoing PH (2.40 ±
0.06% versus 2.31 ± 0.07%, NS), supporting the absence of
grossdiﬀerencesin the extent of tissue resection or liver mass
at baseline.
We evaluated the extent of hepatocyte proliferation
after PH or sham laparotomy by counting the number of
BrdU-labeled hepatocytes and mitotic ﬁgures in paraﬃn-
embedded liver tissue sections. As shown in Figures 3(a)
and 3(b), hepatocyte proliferation is minimal in healthy
WT and Myd88-IFNAR double-KO mice undergoing sham
operations. The number of BrdU-labeled hepatocytes sig-
niﬁcantly increases after PH in both strains of mice, with
a nonsigniﬁcant trend (P = 0.062) towards increased he-
patocyte BrdU labeling at 36h after PH in Myd88-IFNAR
double-KO mice compared with WT mice (Figure 3(a)). The
number of mitotic ﬁgures also increases after PH in both
groups (Figure 3(b)) and is signiﬁcantly higher in Myd88-
IFNAR double-KO mice compared with WT controls at 36h
after PH (P = 0.02). No signiﬁcant diﬀerences between
genotypes are observed at the peak of mitosis (48h after
PH), however. BrdU labeling of NPCs also increases after
PH in both WT and Myd88-IFNAR double-KO mice, but no
signiﬁcantdiﬀerencesbetweenstrainswerenotedatanytime
point (Figure 3(c)). Both groups of mice have similar liver-
to-body weight ratios 48h after sham laparotomy, as well as
remarkably similar liver-to-body weight ratios at 36h, 48h,
and 7 days after PH (Figure 3(d)).
3.4. Abnormal Liver Regeneration in Myd88-IFNAR Double-
KO Mice with Preexisting Liver Pathology. In mice undergo-
ing sham operations, the number of BrdU-positive hepato-
cytes and mitotic ﬁgures tends to be higher in Myd88-IFNAR
double-KOmicewithpreexistingliverlesionscomparedwith
those with grossly normal livers, perhaps as a reﬂection of
ongoing liver injury (Figures 4(a) and 4(b)). Myd88-IFNAR
double-KO mice with preexisting liver pathology, however,
seem to have impaired hepatocyte proliferation after PH
compared with the “healthy” Myd88-IFNAR double-KO
group,bothbythenumberofBrdU-positivehepatocytesand
mitotic ﬁgures (Figures 4(a) and 4(b)). The low number of
cases at each time point impedes formal statistical compar-
isons between these two groups. Noteworthy, the resection
of liver lobules in some mice with preexisting liver lesions
was technically challenging, due to the presence of adhesionsGastroenterology Research and Practice 5
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Figure 3: Liver regeneration after PH in C57Bl6 WT and Myd88-IFNAR double-KO mice without preexisting liver lesions. Shown are (a)
the mean number of BrdU-labeled hepatocytes, (b) the total number of mitotic ﬁgures in hepatocytes, and (c) the mean number of BrdU-
labeled nonparenchymal liver cells (NPCs), counted in eight 200x microscopic ﬁelds per mouse liver in C57Bl6 WT mice (white bars) and
in Myd88-IFNAR double-KO mice (black bars) at the indicated times after PH or sham laparotomy. The number of mice in each group is
indicated below the x-axis. ∗P<0.05. (d) Liver-to-body weight ratios in C57Bl6 WT (white circles) and Myd88-IFNAR double-KO mice
(black circles), measured at the indicated time points after PH or sham laparotomy.6 Gastroenterology Research and Practice
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Figure 4: Impact of preexisting liver lesions on hepatocyte proliferation after partial hepatectomy (PH) in Myd88-IFNAR double-KO mice.
The graphs show (a) the mean number of BrdU-labeled hepatocytes and (b) the total number of mitotic ﬁgures in hepatocytes, counted in
eight 200x microscopic ﬁelds per mouse liver at the indicated times after PH or sham laparotomy in Myd88-IFNAR double-KO mice without
(black bars) and with (hatched bars) preexisting liver lesions. The number of mice in each group is indicated below the x-axis. The dataset
for Myd88-IFNAR double-KO mice without preexisting liver lesions is the same as that shown in Figure 3. The small sample size precludes a
formal statistical analysis.
between the necrotic areas of the liver and surrounding
tissues.
4. Discussion
The present study was performed to investigate Cornell’s
original hypothesis that intestinal microorganisms are essen-
tialtriggersofcytokineactivationandliverregenerationafter
PH [8, 9]. The main ﬁnding of the present study is that liver
regeneration after PH is not impaired by the simultaneous
deﬁciency of Myd88 and IFNAR genes. The Myd88-IFNAR
double-KO paradigm leads to extensive defects in TLR
signaling, as it disrupts all MyD88-dependent pathways as
well as signaling by type I IFNs, which are major mediators
induced by TLRs via MyD88-independent pathways [11].
Notably, previous studies have shown that the response of
the innate immune system to pathogens is more impaired
in Myd88-IFNAR double-KO mice than in mice with single
deﬁciencies of these genes [19–21].
In recent studies, we and others have shown that MyD88,
an adaptor protein for many TLRs and the IL-1R, is re-
quired for cytokine activation after PH [12, 13] and that
signaling via the LPS receptor TLR-4 contributes to up
to 60% of the increase in IL-6 after PH [15]. Liver
regeneration, however, is preserved in Tlr4 KO, Tlr2 KO,
Tlr9 KO, Tlr2,4 double-KO, Tlr2,4,9 triple-KO, Tlr2,4-
caspase-1 triple-KO mice, and, most surprisingly, in mice
lacking Myd88. Though these ﬁndings suggested that TLR
ligands and MyD88 are not essential for liver regeneration,
redundancy among TLRs and signaling downstream of TLRs
via MyD88-independent pathways were still possible [11,
17]. MyD88-independent pathways downstream of TLR-3
and TLR-4 consecutively involve the adaptor protein TIR-
domain-containing adaptor-inducer interferon-β (TRIF),
the activation of interferon regulatory factor-3 (IRF-3),
and the subsequent induction of type I IFNs and other
genes. In the present study, the additional absence of the
type I IFN receptor in Myd88-IFNAR double-KO mice did
not uncover any substantial contributions of this MyD88-
independent pathway to normal liver regeneration. Similar
to our previous study in Myd88 KO mice [15], we even
noted a trend towards an accelerated initiation of hepatocyte
proliferation in Myd88-IFNAR double-KO mice. It should be
noted that TLR signaling may still occur in Myd88-IFNAR
double-KO mice via the TRIF-mediated activation of NF-κB
[11] and that complete abrogation of TLR signaling would
requiretheuseofMyd88-Trif double-KOmice.Despitethese
limitations, the results from the present study conclusivelyGastroenterology Research and Practice 7
demonstrate that type I IFNs are not responsible for the
preservation of liver regeneration in Myd88-deﬁcient mice
and make it less likely that TLR signaling is required for liver
regeneration.
Cytokine activation after PH modulates the expression
of multiple genes involved in liver regeneration, aﬀecting
immune, metabolic, growth-related, apoptosis-related, and
other signaling networks [22]. As assessed by circulating
cytokine levels in the present study, early cytokine activation
after PH consists of a marked increase of IL-6 in WT mice,
whereas the levels of TNF-α,I L - 1 β, IL-12 p70, IL-10, and
IFN-γ remain below the detection range of these assays in
most animals. This observation suggests that the amount of
TLR ligands reaching the liver after PH may be much smaller
than that of experimental systems involving administration
of LPS or pI:pC, which characteristically result in large
increases of these cytokines. Consistent with the previously
published dependence on MyD88 for triggering cytokine
activation after PH, the simultaneous lack of Myd88 and
IFNAR is associated with a marked abrogation of the IL-6
increase,withoutanydetectablechangesinthelevelsofother
cytokines examined. Importantly, Myd88-IFNAR double-
KO mice regenerate normally despite the almost complete
abrogation of the increase in circulating IL-6. Consistent
with what we recently described in Myd88 KO mice, the
initiation of hepatocyte proliferation after PH tended to be
accelerated in the double-KO mice. These ﬁndings suggest
that cytokine activation is not an absolute requirement for
liver regeneration, and, together with previous studies, they
also suggest that cytokine activation after PH may have both
positive andnegative eﬀects on hepatocyte proliferation [23–
25]. In this regard, the deletion of suppressor-of-cytokine-
signaling- (SOCS-) 3 in hepatocytes, a gene that is highly
induced in an IL-6 dependent manner, has been shown to
confer enhanced proliferative capacity to hepatocytes after
PH [25]. The marked attenuation of IL-6 signaling and Socs3
inductionreportedinMyd88 KOmicedemonstratedinprior
studies [13, 15] could thus be a potential explanation for the
preservation of liver regeneration in Myd88-IFNAR double-
KO mice.
An unexpected ﬁnding of the present study was the pres-
ence of gross liver lesions in a considerable portion (28%)
of Myd88-IFNAR double-KO mice. Several studies by other
investigators have used Myd88-IFNAR double-KO mice to
study speciﬁc aspects of immune cell activation and host
defense against a variety of infectious agents, but no gross
physicalanomalieshavebeenreportedinthismousestrain.It
is unclear whether liver lesions passed unnoticed in previous
studies, as a systematic assessment of the liver was not
formally reported as part of their experimental design [19–
21, 26]. Based on the histological appearance of the liver
lesions that we found in Myd88-IFNAR double-KO mice, the
primary etiologic possibilities for these ﬁndings are infec-
tions, ischemia, and toxins. A toxic origin can be discarded,
since no pharmacological agents were administered to the
mice other than inhalational isoﬂuorane at the time of
the surgery, and the lesions were already present at that
point. The distribution of the lesions is atypical for an
ischemic injury, and the mice looked healthy without signs
of hemodynamic compromise or evidence of ischemia in
other organs. We believe that an infection, probably viral,
is the most likely explanation for the lesions observed in
Myd88-IFNAR double-KO mice. Indeed, mice deﬁcient in
IFNAR have an increased susceptibility to and severity of
viral, bacterial, and fungal infections compared to normal
mice [27, 28], and this susceptibility is further enhanced
in Myd88-IFNAR double-KO mice [19, 20]. Nongenetic
factors, such as age of acquisition of the infection or diﬀerent
microbial burden, could explain the incomplete penetrance
of the liver lesions observed in our study. Further work
is needed in order to conclusively determine the cause of
the hepatic lesions in the Myd88-IFNAR double-KO mice,
however.
We conclude that type I IFNs are not responsible for the
preservation of liver regeneration seen in Myd88-deﬁcient
mice. We also suggest that TLR signaling and cytokine acti-
vationarenotabsoluterequirementsfornormalmurineliver
regeneration. Finally, future studies using Myd88-IFNAR
double-KO mice should take into account the potential
presence of gross liver pathology in these animals, as these
lesions could interfere with a diverse range of experimental
results.
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